SEPTIN9 and colorectal carcinoma: Emerging results have shown that cell-free circulating methylated SEPT9 (mSEPT9) is a promising biomarker for CRC detection [23–25], and Epi proColon 2.0 kit for mSEPT9 detection has been developed and approved by the US Food and Drug Administration (FDA).